Compare WDH & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WDH | PSNL |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 647.4M | 746.8M |
| IPO Year | 2021 | 2019 |
| Metric | WDH | PSNL |
|---|---|---|
| Price | $1.73 | $10.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 334.6K | ★ 1.2M |
| Earning Date | 03-11-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | ★ 75.20 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $456,980,701.00 | $69,103,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.60 | $19.39 |
| P/E Ratio | $8.70 | ★ N/A |
| Revenue Growth | ★ 18.55 | N/A |
| 52 Week Low | $1.08 | $2.83 |
| 52 Week High | $2.18 | $11.50 |
| Indicator | WDH | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 38.14 | 59.36 |
| Support Level | $1.71 | $9.01 |
| Resistance Level | $1.85 | $11.50 |
| Average True Range (ATR) | 0.06 | 0.92 |
| MACD | -0.02 | 0.21 |
| Stochastic Oscillator | 4.35 | 69.97 |
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.